Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby Pillinger

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Psychoneuroendocrinology|July 24, 2024
Corrigendum to "Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis" [Psychoneuroendocrinology 150 (2023) 106049]Claudia Aymerich, Borja Pedruzo, Malein Pacho, et al.
The Lancet. Psychiatry|January 12, 2023
Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational studyToby Pillinger, Emanuele F Osimo, Antonio de Marvao, et al.
The Lancet. Psychiatry|July 5, 2025
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panelDan Siskind, Korinne Northwood, Toby Pillinger, et al.
Schizophrenia Bulletin|May 11, 2026
Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysisJack B Fanshawe, Cameron J Watson, Valentina Mancini, et al.
Translational Psychiatry|August 13, 2021
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging studyKatherine Beck, Atheeshaan Arumuham, Mattia Veronese, et al.
Brain, Behavior, and Immunity|April 9, 2025
Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosisClaudia Aymerich, Borja Pedruzo, Gonzalo Salazar de Pablo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 15, 2026
New approaches to clinical research for people with schizophreniaKatherine Beck, Matthew Broome, Saeed Farooq, et al.
The Australian and New Zealand Journal of Psychiatry|April 26, 2026
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendationsNicola Warren, Cullen O'Gorman, Frances Dark, et al.
Journal of Psychopharmacology (Oxford, England)|September 19, 2022
The association between <i>N</i>-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controlsKatherine Beck, Atheeshaan Arumuham, Stefan Brugger, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Psychoneuroendocrinology|July 24, 2024
Corrigendum to "Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis" [Psychoneuroendocrinology 150 (2023) 106049]Claudia Aymerich, Borja Pedruzo, Malein Pacho, et al.
The Lancet. Psychiatry|January 12, 2023
Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational studyToby Pillinger, Emanuele F Osimo, Antonio de Marvao, et al.
The Lancet. Psychiatry|July 5, 2025
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panelDan Siskind, Korinne Northwood, Toby Pillinger, et al.
Schizophrenia Bulletin|May 11, 2026
Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysisJack B Fanshawe, Cameron J Watson, Valentina Mancini, et al.
Translational Psychiatry|August 13, 2021
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging studyKatherine Beck, Atheeshaan Arumuham, Mattia Veronese, et al.
Brain, Behavior, and Immunity|April 9, 2025
Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosisClaudia Aymerich, Borja Pedruzo, Gonzalo Salazar de Pablo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 15, 2026
New approaches to clinical research for people with schizophreniaKatherine Beck, Matthew Broome, Saeed Farooq, et al.
The Australian and New Zealand Journal of Psychiatry|April 26, 2026
Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendationsNicola Warren, Cullen O'Gorman, Frances Dark, et al.
Journal of Psychopharmacology (Oxford, England)|September 19, 2022
The association between <i>N</i>-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controlsKatherine Beck, Atheeshaan Arumuham, Stefan Brugger, et al.
Pageof 9